A tremendous number of government and private policies affecting kids are based on one number: 335. That is how many children under 18 have died with a Covid diagnosis code in their record, according to the Centers for Disease Control and Prevention. Yet the CDC, which has 21,000 employees, hasn't researched each death to find out whether Covid caused it or if it involved a pre-existing medical condition.

Without these data, the CDC Advisory Committee on Immunization Practices decided in May that the benefits of two-dose vaccination outweigh the risks for all kids 12 to 15. I've written hundreds of peer-reviewed medical studies, and I can think of no journal editor who would accept the claim that 335 deaths resulted from a virus without data to indicate if the virus was incidental or causal, and without an analysis of relevant risk factors such as obesity.

My research team at Johns Hopkins worked with the nonprofit FAIR Health to analyze approximately 48,000 children under 18 diagnosed with Covid in health-insurance data from April to August 2020. Our report found a mortality rate of zero among children without a pre-existing medical condition such as leukemia. If that trend holds, it has significant implications for healthy kids and whether they need two vaccine doses. The National Education Association has been debating whether to urge schools to require vaccination before returning to school in person. How can they or anyone debate the issue without the right data?

A capsule version of the Covid-19 vaccine could be a "game changer" in countries with a low immunization rate, its developer has said.

Jerusalem-based Oramed Pharmaceuticals has received approval from the Tel Aviv Sourasky Medical Center to start a clinical trial on 24 unvaccinated volunteers for a single-dose capsule version of a vaccine that is being developed by Indian firm Premas Biotech.

The UK Government / MHRA have released the 24th update on adverse reactions to the Covid-19 vaccines which have been reported to the Yellow Card scheme, and this week we delved deeper into the report than ever before and discovered an extremely concerning set of reactions which have been overlooked - birth defects.

The Medicine and Healthcare Products Regulatory Agency (MHRA) gave emergency approval to the Pfizer / BioNTech mRNA jab on the 8th December 2021. Since this date, the MHRA Yellow Card scheme has been open to the public, doctors, and nurses; allowing them to report any adverse reactions that may have occurred due to any of the Covid-19 vaccines.

The first report released by the UK Government / MHRA in early February covered adverse reactions which had been reported up to the 24th January 2021. This report included reactions such as blindness, stroke, miscarriage, sudden death, and many other fatalities.

The Health Ministry reported Thursday the efficacy of Pfizer's coronavirus vaccine in preventing infection has dropped to 39% but the effectiveness in preventing severe illness still remains relatively high.


These figures were published three weeks after Ynet first revealed the decline in the effectiveness of the Pfizer vaccine against the Delta variant.

Eminent European physicians and scientists this month co-authored an expert statement regarding Comirnaty-COVID-19 mRNA vaccine for children, outlining their expert opinions that "vaccination of adolescents for COVID-19 is unnecessary, claims demonstrating efficacy are misleading, and the safety profiles are catastrophic."

This is the ninth of the regular round-ups of Covid vaccine safety reports and news compiled by a group of medical doctors who are monitoring developments but prefer to remain anonymous in the current climate (find the eighth one here). By no means is this part of an effort to generate alarm about the vaccines or dissuade anyone from getting inoculated. It should be read in conjunction with the Daily Sceptic's other posts on vaccines, which include both encouraging and not so encouraging developments.

At the Daily Sceptic we report all the news about the vaccines whether positive or negative and give no one advice about whether they should or should not take them. Unlike with lockdowns, we are neither pro-vaccine nor anti-vaccine; we see our job as reporting the facts, not advocating for or against a particular policy. The vaccine technology is novel and the vaccines have not yet fully completed their trials, which is why they're in use under temporary and not full market authorisation.

This has been done on account of the emergency situation and the trial data was largely encouraging on both efficacy and safety. For a summary of that data, see this preamble to the Government's page on the Yellow Card reporting system. (Dr Tess Lawrie recently wrote an open letter to Dr June Raine, head of the MHRA, arguing that: "The MHRA now has more than enough evidence on the Yellow Card system to declare the COVID-19 vaccines unsafe for use in humans," a claim that has been "fact checked" here.) We publish information and opinion to inform public debate and help readers reach their own conclusions about what is best for them, based on the available data.

We've known since the early weeks of the pandemic that age is the single best predictor of COVID-19 mortality, and that the risk of death for young people is vanishingly small.

A letter in the New England Journal of Medicine reported that zero Swedish children aged 1-16 died of COVID-19 up to the end of June 2020. And only 15 were admitted to the ICU, of whom four had a serious underlying health condition.

Of course, England is a much larger country than Sweden, and it's been a whole other year since those Swedish data were collected. So how many English children have died of COVID-19?

In an unpublished study, Clare Smith and colleagues sought to identify the number of COVID-19 deaths among people aged under 18 between March 2020 and February 2021. They examined data from the National Child Mortality Database, which was linked to testing data from Public Health England and comorbidity data from national hospital admissions.

Every week it seems like more and more jaw-dropping news is coming out about Covid shots. On this episode of Objective:Health, we cover the latest news on the mRNA and other shots, including: Dr. Yeadon warning that children are 50 times more likely to die from the vaccines than from Covid; Mercola reporting that to prevent three deaths the Covid jab kills two; rare autoimmune hepatitis coming from the Covishield vaccine and a British report calling for an the end to the Covid vaccination campaign.

Join us on this episode of Objective:Health as we talk about all the Covid vaccine information you're not going to see on the evening news!


For other health-related news and more, you can find us on:

♥Twitter: https://twitter.com/objecthealth
♥Facebook: https://www.facebook.com/objecthealth/
♥Brighteon: https://www.brighteon.com/channel/objectivehealth
♥LBRY: https://lbry.tv/@objectivehealth:f
♥Odysee: https://odysee.com/@objectivehealth:f

And you can check out all of our previous shows (pre YouTube) here:

♥https://docs.google.com/spreadsheets/d/16H-nK-N0ANdsA5JFTT12_HU5nUYRVS9YcQh331dG2MI/edit?usp=sharing

Running Time: 00:32:29

Download: MP3 — 29.7 MB

One commonly used trick in drug trials is to exclude any group that might make the drug look worse, such as those that are more likely to experience side effects. A good recent example of this is the covid vaccine trials, which largely excluded people with auto-immune diseases (more likely to develop an auto-immune disease after vaccination), people with allergies (more likely to have an allergic reaction to the vaccine), and, of course, the elderly (less likely to develop immunity after getting the vaccine, and more likely to become seriously sick from it).

These three groups are all frequently excluded from trials, and the exclusion is particularly galling when it comes to the elderly, because they are a big segment of the population, and they are also usually the most likely to end up actually using the drugs being tested.

When drug companies have gotten a drug approved, and move on to market the drug, they will studiously avoid mentioning the fact that large segments of the population were excluded from the trials. When drug reps show their flashy powerpoints to gatherings of doctors, say for a new drug to lower blood pressure, they will always present impressive looking graphs of benefit, and they will of course point out how safe their drug was shown to be in the trials. Not once will they mention that the groups of patients the doctors will primarily be prescribing the drug to weren't even included in the trials.

The doctors will then happily go off and prescribe the drug to multi-morbid 90 year olds, which might explain why prescription drugs are now the third leading cause of death in the western world.

The manipulation of who is included in trials is probably one of the main reasons why findings of side effects always end up being much higher in reality than in clinical trials. It might explain, for example, why muscle pain is a massively common side effect of statins in the real world, while being vanishingly rare in the statin trials (as Dr. Malcolm Kendrick has written about in detail).

A standard face masks act as nothing more than a "comfort blanket" and offers little protection against Covid, a scientific adviser to SAGE has said ahead of the partial easing of the mask mandate on Monday. The Telegraph has the story.